Skip to main content

Table 3 Summary of trials which investigated treatment outcome

From: A systematic review of community based hepatitis C treatment

Study Facility N Age (years) Gender (% male) Genotype 1 (%) HIV infected n (%) Prior treatment Fibrosis assessment Fibrosis result SVR
Mean or % n (%)
Arora Tertiary 146 45 45 57 0 Naive APRI 0.938 84 (58)
Telehealth 261 42 73 56 0 0.935 152 (58)
Bruce Tertiary 9 43 67 67 (G1&4) 3 (33) N/P Biopsy (G1 only) F4 33 % 1 (33)
Primary 12 40 42 67 (G1&4) 3 (25) F4 25 % 6 (75)
Chen Tertiary 150 52 N/P 58 0 Naive   N/P 99 (66)
Primary 148 47 N/P 61 0 N/P 102 (69)
Jou Academic 1905 48 59 100 0 Naive Biopsy F3/4 10 % 760 (40)
Community 1165 47 61 100 0 F3/4 11 % 455 (39)
Kuo Preintervention 18 57 33 N/P N/P N/P   N/P 2 (50)
Post intervention 3 (100)
Myers Academic 133 46 70 49 0 Naïve & experienced Biopsy F4 14 % 79 (59)
Community 250 46 64 55 0 F4 10 % 120 (48)
Nazareth Tertiary 528 43 65 N/P N/P Naïve & experienced Biopsy or Hepascore F4 19 % 311 (59)
Telehealth 50 46 50 60 N/P Hepascore F4 20 % 36 (72)
Niedaerau Hospital based 621 N/P N/P 100 N/P N/P   N/P 290 (47)
Private practice 3778 N/P N/P 100 N/P N/P 1744 (46)
Rossaro Tertiary 40 54 55 65 0 Naive Biopsy F4 45 % 16 (43)
Telehealth 40 51 48 65 0 F4 28 % 21 (55)
  1. N/P not provided